CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C03901 | BRD-K76725781 | ONO-8130 | PTGER1 | prostanoid receptor antagonist | Details | |
C03902 | BRD-K60446698 | ONX-0914 | proteasome inhibitor | Details | ||
C03903 | BRD-K88554883 | ON123300 | CDK4|NUAK1|PDGFRB | CDK inhibitor | Details | |
C03904 | BRD-K19426040 | OPC-21268 | AVPR1A|AVPR2|OXTR | vasopressin receptor antagonist | Details | |
C03905 | BRD-K66192203 | opicapone | COMT | catechol O methyltransferase inhibitor | Details | |
C03906 | BRD-K43786866 | opipramol | sigma receptor agonist | Details | ||
C03907 | BRD-A36331462 | oprozomib | proteasome inhibitor | Details | ||
C03908 | BRD-K18602506 | OR-486 | COMT | catechol O methyltransferase inhibitor | Details | |
C03909 | BRD-K55966568 | orantinib | AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB | FGFR inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor | Details | |
C03910 | BRD-K63001556 | orbifloxacin | bacterial DNA gyrase inhibitor | Details | ||
C03911 | BRD-K67068943 | ORE1001 | ACE2 | angiotensin converting enzyme inhibitor | Details | |
C03912 | BRD-K07409305 | Org-12962 | HTR2A|HTR2B|HTR2C | serotonin receptor agonist | Details | |
C03913 | BRD-K32853922 | Org-25543 | GLRB|SLC6A5 | glycine transporter inhibitor | Details | |
C03914 | BRD-K40002998 | org-26576 | glutamate receptor modulator | Details | ||
C03915 | BRD-K57597776 | org-27569 | CNR1 | cannabinoid receptor modulator | Details | |
C03916 | BRD-K41434598 | org-9768 | ADRA2A | adrenergic receptor antagonist | Details | |
C03917 | BRD-K23925186 | oridonin | BCL2 | BCL inhibitor | Details | |
C03918 | BRD-A33352494 | oritavancin | bacterial cell wall synthesis inhibitor | Details | ||
C03919 | BRD-K94062100 | orlistat | CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP | lipase inhibitor | Details | |
C03920 | BRD-A42759514 | ornidazole | antiprotozoal agent | Details | ||
C03921 | BRD-A13561534 | ornithine | ARG1|ARG2|GATM|GPRC6A|OAT|OAZ1|OAZ2|OAZ3|OTC|SLC25A15|SLC25A2|SLC7A1|SLC7A2|SLC7A3|SLC7A4 | NFkB pathway modulator | Details | |
C03922 | BRD-K32572029 | orotic-acid | DHODH | Details | ||
C03923 | BRD-K05717154 | orphanin-fq | OPRL1|OPRM1 | opioid receptor agonist | Details | |
C03924 | BRD-A53576514 | orphenadrine | GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2 | acetylcholine receptor antagonist | Details | |
C03925 | BRD-K00674894 | orteronel | CYP17A1 | androgen biosynthesis inhibitor; androgen receptor antagonist; cytochrome P450 inhibitor | Details | |
C03926 | BRD-K59711701 | ORY-1001 | KDM1A | histone lysine demethylase inhibitor | Details | |
C03927 | BRD-K93767137 | oseltamivir-carboxylate | neuraminidase inhibitor | Details | ||
C03928 | BRD-K76011241 | oseltamivir-phosphate | CES1|NEU1|NEU2 | neuraminidase inhibitor | Details | |
C03929 | BRD-K60371362 | osemozotan | HTR1A | serotonin receptor agonist | Details | |
C03930 | BRD-K87124298 | OSI-027 | MTOR | mTOR inhibitor | Details | |
C03931 | BRD-K73309154 | OSI-420 | EGFR | EGFR inhibitor | Details | |
C03932 | BRD-K25340465 | OSI-930 | KDR|KIT | KIT inhibitor; VEGFR inhibitor | Details | |
C03933 | BRD-K42805893 | osimertinib | EGFR | EGFR inhibitor | Details | |
C03934 | BRD-K44184170 | ospemifene | ESR1|ESR2 | selective estrogen receptor modulator (SERM) | Details | |
C03935 | BRD-K29735307 | ostarine | AR | androgen receptor modulator | Details | |
C03936 | BRD-K78294846 | osthol | calcium channel blocker | Details | ||
C03937 | BRD-K42009284 | OT-R-antagonist-1 | AVPR1A|OXTR | oxytocin receptor antagonist | Details | |
C03938 | BRD-K80082640 | otamixaban | F10 | coagulation factor inhibitor | Details | |
C03939 | BRD-A00520476 | otenzepad | CHRM1|CHRM2|CHRM3|CHRM4|CHRM5 | acetylcholine receptor antagonist | Details | |
C03940 | BRD-K85337334 | otilonium | CACNA1C | acetylcholine receptor antagonist | Details | |
C03941 | BRD-K53417444 | OTS167 | MELK | maternal embryonic leucine zipper kinase inhibitor | Details | |
C03942 | BRD-K38018935 | OTS514 | TOPK inhibitor | Details | ||
C03943 | BRD-K43471985 | OTX015 | BRD2|BRD3|BRD4 | bromodomain inhibitor | Details | |
C03944 | BRD-K33277808 | ouabain | ATP1A1 | ATPase inhibitor | Details | |
C03945 | BRD-K98736329 | OXA-06 | ROCK1|ROCK2 | rho associated kinase inhibitor | Details | |
C03946 | BRD-K96786677 | oxacillin | bacterial cell wall synthesis inhibitor | Details | ||
C03947 | BRD-K36982194 | oxacyclohexadecan-2-one | protein kinase inhibitor | Details | ||
C03948 | BRD-K78960041 | oxaliplatin | DNA inhibitor | Details | ||
C03949 | BRD-K61279411 | oxaloacetate | CS|SPR | glutamate release inhibitor | Details | |
C03950 | BRD-K92467929 | oxandrolone | AR | androgen receptor agonist | Details | |
C03951 | BRD-K66019333 | oxantel | anthelmintic agent | Details | ||
C03952 | BRD-K25394294 | oxaprozin | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C03953 | BRD-K02079473 | oxatomide | HRH1 | histamine receptor antagonist | Details | |
C03954 | BRD-A50049929 | oxazepam | GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3 | GABA benzodiazepine site receptor agonist | Details | |
C03955 | BRD-K04196797 | oxcarbazepine | SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A | sodium channel blocker | Details | |
C03956 | BRD-K17977438 | oxelaidin | antitussive | Details | ||
C03957 | BRD-K56940463 | oxethazaine | local anesthetic | Details | ||
C03958 | BRD-A73891132 | OXF-BD-02 | BRD4 | bromodomain inhibitor | Details | |
C03959 | BRD-A33447119 | oxfendazole | anthelmintic agent | Details | ||
C03960 | BRD-K30373577 | oxfenicine | CPT1A|CPT1B | carnitine palmitoyltransferase inhibitor | Details | |
C03961 | BRD-K52075715 | oxibendazole | TUBB|TUBB4B | tubulin polymerization inhibitor | Details | |
C03962 | BRD-K56104152 | oxiconazole | bacterial cell wall synthesis inhibitor | Details | ||
C03963 | BRD-K41809988 | oxidopamine | neurotoxin | Details | ||
C03964 | BRD-K20417253 | oxiniacic-acid | Details | |||
C03965 | BRD-K78096648 | oxiperomide | dopamine receptor antagonist | Details | ||
C03966 | BRD-K50677762 | oxiracetam | acetylcholine receptor agonist | Details | ||
C03967 | BRD-K42596464 | oxolamine | antitussive | Details | ||
C03968 | BRD-K73394555 | oxolinic-acid | bacterial DNA gyrase inhibitor | Details | ||
C03969 | BRD-K31468676 | oxonic-acid | uricase inhibitor | Details | ||
C03970 | BRD-K01942991 | oxotremorine-m | CHRM1|CHRM2|CHRM3|CHRM4 | acetylcholine receptor agonist | Details | |
C03971 | BRD-K21936341 | oxotremorine-sesquifumarate | CHRM1|CHRM2|CHRM3|CHRM4 | cholinergic receptor agonist | Details | |
C03972 | BRD-A43671941 | oxprenolol | ADRB1|ADRB2 | adrenergic receptor antagonist | Details | |
C03973 | BRD-K97799481 | oxtriphylline | ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE4A|PDE4B|PDE5A | adenosine receptor antagonist | Details | |
C03974 | BRD-K59037100 | oxybenzone | LIPE | lipase inhibitor | Details | |
C03975 | BRD-K04185004 | oxybuprocaine | SCN10A | local anesthetic | Details | |
C03976 | BRD-A65013509 | oxybutynin | CHRM1|CHRM2|CHRM3 | acetylcholine receptor antagonist | Details | |
C03977 | BRD-K07283971 | oxyclozanide | Details | |||
C03978 | BRD-K73027814 | oxyfedrine | adrenergic receptor agonist | Details | ||
C03979 | BRD-A57833392 | oxymatrine | Details | |||
C03980 | BRD-K16195444 | oxymetazoline | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C | adrenergic receptor agonist | Details | |
C03981 | BRD-A93291428 | oxymetholone | AR | androgen receptor agonist | Details | |
C03982 | BRD-A33749298 | oxyphenbutazone | PLA2G2E|PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C03983 | BRD-A58193911 | oxyphencyclimine | CHRM1|CHRM2|CHRM3 | cholinergic receptor antagonist | Details | |
C03984 | BRD-A14208071 | oxyphenonium | CHRM1 | cholinergic receptor antagonist | Details | |
C03985 | BRD-K31841515 | oxypurinol | XDH | xanthine oxidase inhibitor | Details | |
C03986 | BRD-K66808046 | oxyquinoline | METAP2 | chelating agent | Details | |
C03987 | BRD-A22740840 | oxytetracycline | bacterial 30S ribosomal subunit inhibitor | Details | ||
C03988 | BRD-K25243230 | oxytocin | AVPR1A|AVPR1B|AVPR2|OXTR | oxytocin receptor agonist | Details | |
C03989 | BRD-K53061490 | ozagrel | TBXAS1 | thromboxane synthase inhibitor | Details | |
C03990 | BRD-K46625559 | ozanimod | S1PR1 | sphingosine 1 phosphate receptor agonist | Details | |
C03991 | BRD-A72297358 | ozolinone | diuretic | Details | ||
C03992 | BRD-K53849769 | O4I1 | POU5F1 | Oct inducer | Details | |
C03993 | BRD-K92041145 | O6-Benzylguanine | MGMT | O6-alkylguanine-DNA alkyltransferase inhibitor | Details | |
C03994 | BRD-K42336459 | p-dimethylinamyl-benzoate | Details | |||
C03995 | BRD-K11428250 | PA-452 | RXRA | retinoid receptor antagonist | Details | |
C03996 | BRD-K96671969 | PA-824 | FASN | nitric oxide donor | Details | |
C03997 | BRD-K92991072 | PAC-1 | CASP3 | caspase activator | Details | |
C03998 | BRD-K62008436 | paclitaxel | BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1 | tubulin polymerization inhibitor | Details | |
C03999 | BRD-K05677083 | PACOCF3 | PLA2G4A | phospholipase inhibitor | Details | |
C04000 | BRD-K19034817 | pacritinib | FLT3|JAK1|JAK2|JAK3 | FLT3 inhibitor; JAK inhibitor | Details |